Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dueren C et al. – Included patients benefited subjectively and objectively from the use of rhTSH for diagnostic procedures in the treatment of DTC. A clear preference (127 of 128) of analyzed patients could be identified for exogenous stimulation with rhTSH.

Related Articles

Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: Report of a case
Surgery Today, 10/06/09    Relevance Score: 69%

S100A8 and S100A9 Expression Is a Crucial Factor for Dedifferentiation in Thyroid Carcinoma
Anticancer Research, 11/11/09    Relevance Score: 68%

Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the Young
Thyroid, 11/06/09    Relevance Score: 68%

A Proposal for a Thyroid Imaging Reporting and Data System for Ultrasound Features of Thyroid Carcinoma
Thyroid, 10/12/09    Relevance Score: 68%

Thyroid Ultrasonography
World Journal of Surgery, 10/20/09    Relevance Score: 67%

Today in Endocrine Oncology...keeping you current

Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09

Malignant teratoma of the thyroid in a pregnant woman
Annals of Diagnostic Pathology, 11/23/09

Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
European Journal of Endocrinology, 11/19/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address